CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
27.68
0.4%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023679 %
Charges from full value of position ($-4.50)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023679%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001457 %
Charges from full value of position ($0.28)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001457%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 27.65
Open 27.46
1-Year Change -14.29%
Day's Range 27.46 - 27.88
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 1, 2025 27.65 -0.10 -0.36% 27.75 28.03 27.31
Mar 31, 2025 27.97 0.42 1.52% 27.55 28.13 27.54
Mar 28, 2025 28.01 0.63 2.30% 27.38 28.10 27.23
Mar 27, 2025 27.68 0.35 1.28% 27.33 27.72 27.26
Mar 26, 2025 27.30 0.49 1.83% 26.81 27.44 26.81
Mar 25, 2025 27.14 -0.57 -2.06% 27.71 27.71 27.05
Mar 24, 2025 27.69 0.06 0.22% 27.63 27.91 27.56
Mar 21, 2025 27.88 -0.10 -0.36% 27.98 28.25 27.74
Mar 20, 2025 28.43 0.95 3.46% 27.48 28.57 27.41
Mar 19, 2025 27.83 -0.02 -0.07% 27.85 28.09 27.52
Mar 18, 2025 27.80 -0.12 -0.43% 27.92 28.98 27.68
Mar 17, 2025 28.21 1.20 4.44% 27.01 28.51 27.01
Mar 14, 2025 27.20 0.58 2.18% 26.62 27.25 26.46
Mar 13, 2025 26.67 -0.51 -1.88% 27.18 27.53 26.67
Mar 12, 2025 27.43 -0.07 -0.25% 27.50 27.89 27.24
Mar 11, 2025 27.80 0.65 2.39% 27.15 28.08 26.90
Mar 10, 2025 27.37 -0.06 -0.22% 27.43 27.99 27.26
Mar 7, 2025 27.63 -0.41 -1.46% 28.04 28.45 27.57
Mar 6, 2025 28.57 -0.44 -1.52% 29.01 29.22 28.38
Mar 5, 2025 29.40 0.41 1.41% 28.99 29.47 28.68

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Perrigo Company profile

About Perrigo Company PLC

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Perrigo Company PLC revenues increased 1% to $4.14B. Net loss before extraordinary items totaled $130.9M vs. income of $44.2M. Revenues reflect CSCI segment increase of 4% to $1.45B, CSCA segment remaining flat at $2.69B, Europe segment increase of 3% to $1.39B. Net loss reflects CSCA segment income decrease of 56% to $206.5M. Dividend per share increased from $0.90 to $0.96.

Equity composition

Common Stock no Par, 08/11, 200M auth., 92,797,375 issd. Insiders own 7.05%. IPO: 10/93, 13Mshares @ $31 by J.P. Morgan Securities Inc. 8/93, 2-for-1 stock split. FY'02 & Q's are restated. FY'03 & '04 Summ. Q's reflect the reclassification. FY'04 Q's are reclassified.

Industry: Pharmaceuticals (NEC)

The Sharp Building
Hogan Place
DUBLIN
DUBLIN
IE

People also watch

BTC/USD

86,555.25 Price
+1.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

19,501.90 Price
+0.520% 1D Chg, %
Long position overnight fee -0.0237%
Short position overnight fee 0.0015%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

2.15 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01073

ETH/USD

1,903.25 Price
-0.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading